Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
ABSTRACT
Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety. According to the World Health Organization, some poor quality drugs are deliberately and fraudulently mislabeled with respect to identity or source while...
The US food system is widely recognized as one of the safest in the world. Nevertheless, about one in every six American is sick every year from eating a contaminated food product. Food safety incidents often make the news and many perceive the US food system as vulnerable.
Abstract:
This study assesses the trade-off between drug safety and price savings in online drug purchases. Focusing on five brand-name prescription drugs, we acquire 370 drug samples from 41 online pharmacies and test their authenticity. Of the 41 websites, 8 are clearly US-based and verified by the National Association of...
Evidence from numerous studies shows that emerging markets have far more poor quality drugs than western markets. There are many reasons for this, but one reason, investigated in this paper, is the possibility that smaller, often privately-owned, pharmacies take greater risks with drug procurement than larger organizations, which are often franchises or major pharmacy chains.
This paper explores the opportunities presented by the Trans-Pacific Partnership (TPP) to Japan to revitalize its trade policy, bolster economic growth, and increase participation in regional multilateral fora for the 21st century. Despite its strengths, Japan has continued to face problems caused by its economic, political,...
The relationship between the U.S. and the People's Republic of China is multifaceted and goes well beyond economic relations, but questions of macroeconomic imbalances have remained at the heart of bilateral discussions between the two.
Biologics are essential to oncology care. As patents for older biologics begin to expire, the United States is developing an abbreviated regulatory process for the approval of similar biologics, which raises important considerations for the safe and appropriate incorporation of biosimilars into clinical practice for patients with cancer.
Well-meaning laws sometimes backfire. It's especially true when they are passed in reaction to media frenzies driven by ideology, not science. That's what's happening in the US and Europe, where advocacy groups are raising new alarms about bisphenol A (aka BPA), a controversial plastic component used to prevent spoilage in myriad products, including containers, dental sealants, and epoxy linings.






